MEDICA Sensational Debut! 10-Minute Rapid Nucleic Acid Test, Breaking Through Size Barriers Once and For All!
updated time：2025-11-18
On November 17, 2025, MEDICA – the annual flagship event of the global healthcare industry – officially kicked off along the Rhine River in Düsseldorf, Germany. Recognized as one of the world’s premier exhibitions for hospital and medical equipment, this year’s MEDICA maintained its leading position in the sector, gathering over 5,000 exhibitors from more than 140 countries and regions. Its exhibits span the entire healthcare value chain, including medical devices, laboratory technology, in vitro diagnostics, and healthcare IT solutions.
GenDx made a brilliant debut at the exhibition with innovative diagnostic technologies, showcasing the professional strength of China's in vitro diagnostics (IVD) to the world through its solutions that combine precision and efficiency. At the venue, GenDx unveiled its next-generation 10-minute nucleic acid rapid test solution – which requires no large-scale equipment – to the public for the first time, attracting widespread attention.
In the field of molecular diagnostics, balancing accuracy and timeliness has long been an industry challenge. GenDx’s core technologies showcased this time have achieved dual breakthroughs through underlying technological innovations, with five key advantages directly addressing clinical pain points:
Equipment Free: Enables efficient operation effortlessly, freeing users from equipment constraints for greater convenience. Focused on "zero equipment threshold, instant startup, and flexible scenarios," it brings high efficiency into daily applications.
Equal to qPCR: Results are equivalent to qPCR, a core advantage derived from advanced nucleic acid amplification technology. It provides reliable basis for clinical diagnosis and breaks the industry misconception that "rapid testing equals compromised accuracy."
Ultra Fast: ERA technology shortens detection time to 10 minutes, while multiplex detection protocols can complete simultaneous multi-target testing in only 20 minutes. Compared with the several-hour testing cycle of traditional diagnostics, this technology significantly reduces report turnaround time. It is particularly suitable for rapid diagnosis scenarios, striving for the golden window of treatment for patients.
Superior Bio-safety: Adopts a fully enclosed detection system and disposable dedicated consumables, eliminating the risk of aerosol leakage throughout the entire process from sample loading to result output.
User-Friendly：No professional experimental operation background is required, and operators can get started after simple training. The instrument integrates full-process automated functions including sample processing, nucleic acid extraction, and amplification detection, completing the test in only three steps. This greatly lowers the threshold for use in scenarios such as primary medical institutions.
The integration of these advantages enables GenDx’s testing solutions to adapt to diverse scenarios such as primary medical care and emergency prevention and control, truly realizing "accurate testing anytime, anywhere."
The exhibition booth was bustling with activity. Merchants from home and abroad around the world stopped to linger, with figures consulting and communicating shuttling endlessly, and the sound of negotiations echoing continuously. Moreover, some customers were deeply impressed by GenDx’s core products and innovative solutions, and launched in-depth discussions with us on the spot for as long as two hours. Covering technical details to customized needs, from the current status of IVD diagnostics to the future development of general health, the two parties exchanged in meticulous detail and left both parties wanting more. The on-site negotiation atmosphere was enthusiastic and intense, fully demonstrating the exhibition’s strong appeal and industry influence.
Warmly Invite You to Visit & Explore the Future of Diagnostic Innovation
Exhibition Period: November 17-20Venue: Düsseldorf Exhibition Center, GermanyBooth Number: Hall 3, Booth 3F92-7 Amid the escalating global demand for healthcare, GenDx remains committed to the globalization of its 10-minute ERA nucleic acid rapid testing technology. We strive to tackle the challenges of infection detection, leveraging genetic technology to guard public health. This participation in MEDICA is not only a demonstration of our technical strength but also an invitation for open cooperation. The exhibition is still underway—we look forward to your visit to our booth for face-to-face communication in Düsseldorf. Let’s jointly promote the progress of global diagnostic technologies and bring efficient, accurate medical services to more patients.
